bill Non-partisan · AI-drafted, editor-reviewed

Misuse of Drugs (Pseudoephedrine) Amendment Bill

Member in charge: David Seymour
In short: Arapono’s summary

This bill makes it easier to buy cold and flu medicines that contain pseudoephedrine. Right now, pseudoephedrine is treated as a higher-risk controlled drug, meaning you need a prescription to get it. The bill moves it to a lower-risk category, so pharmacies will be able to sell cold and flu products containing pseudoephedrine over the counter — without you needing to see a doctor first. The changes take effect the day after the bill is signed into law.

What this affects

Tap a topic to see how this bill touches it, and the parts of the text that show it.

People will be able to buy cold and flu medicines containing pseudoephedrine at a pharmacy without needing a prescription from a doctor.

From the bill

This Bill reclassifies pseudoephedrine from a Class B2 to a Class C3 controlled drug under the Misuse of Drugs Act 1975, so that cold and flu products containing pseudoephedrine can be sold in pharmacies without a prescription.

Pseudoephedrine is being added to Part 3 of Schedule 3, which means it will be a partially exempted drug as defined under the Misuse of Drugs Regulations 1977.

replaces the definition of partially exempted drug to remove the dosage limitation that currently applies to pseudoephedrine in order for it to be considered a partially exempted drug

Progress through Parliament

Introduced
First Reading
Select committee
Second Reading
Whole House
Third Reading
Royal Assent
Current stage: Royal Assent

Have your say

This bill is open for public submissions to the Health Committee. Anyone can tell the committee what they think, and you don’t need to be an expert. Submissions close 29 February 2024.

View the official bill on legislation.govt.nz

Bill text sourced from legislation.govt.nz (Parliamentary Counsel Office). Arapono’s summary and breakdown are drafted with AI grounded in that official text and reviewed by an Arapono editor for accuracy and neutrality before publishing. Arapono is non-partisan and takes no position on this bill.